APA

Quercioli A., Luciano Viviani G., Dallegri F., Mach F. & Montecucco F. (20110413). Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification. : Critical pathways in cardiology.

Chicago

Quercioli Alessandra, Luciano Viviani Giorgio, Dallegri Franco, Mach François and Montecucco Fabrizio. 20110413. Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification. : Critical pathways in cardiology.

Harvard

Quercioli A., Luciano Viviani G., Dallegri F., Mach F. and Montecucco F. (20110413). Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification. : Critical pathways in cardiology.

MLA

Quercioli Alessandra, Luciano Viviani Giorgio, Dallegri Franco, Mach François and Montecucco Fabrizio. Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification. : Critical pathways in cardiology. 20110413.